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Dear Friends,
I am pleased to share with you our 2006 Cancer Care Annual Report, which
provides a comprehensive overview of the outstanding pediatric oncology
program offered at Children’s Mercy Hospitals and Clinics.
This year’s issue includes a special focus on tumors of
the central nervous system and the ground-breaking
work that Children’s Mercy is doing in this area.
This has been a particularly stellar year for our oncology
program, as Children’s Mercy was the only pediatric
hospital in the nation to receive the Outstanding
Achievement Award from the American College of
Surgeons Commission on Cancer. Only 31 hospitals in
the entire nation received this prestigious award, which
recognizes the significant commitment made in providing
high quality cancer care to our patients and exceeding
the standards of excellence set by the Commission
on Cancer Approvals Program. I offer my heartfelt
congratulations and appreciation to Drs. Woods and
Gamis, and the entire Hematology/Oncology staff for this
notable achievement.
I hope you will take a few minutes to enjoy this year’s
annual report and find out more about why our oncology
program has received such well-deserved national
recognition. We certainly enjoy receiving these types of
awards. However, the greatest reward our oncology staff
receives throughout the year is the ability to provide both cutting-edge and
supportive care to ensure bright futures for hundreds of children with cancer
and their families.
Sincerely,

Randall L. O’Donnell, PhD
President and Chief Executive Officer
Children’s Mercy Hospitals and Clinics



Dear Friends,
This year’s Children’s Mercy Hospitals
and Clinics Cancer Center Annual
Report focuses upon the second
most common tumor in childhood,
Brain Tumors. Of all the tumors seen
in childhood, these are among the
most complex due to their location,
their significant impact upon the
child even before diagnosis, and
the limitations placed upon therapy
options due to the young age of most
patients at the time of diagnosis.
This latter item, age at diagnosis,
plays a significant role in the ultimate
outcome of these children, both as
it relates to cure as well as to quality
of life after cure. The average age
of children diagnosed with a brain
tumor is eight years, with 25 percent
diagnosed <3 yrs of age, 27 percent
between 3-8 yrs of age, and 48
percent >8 yrs of age. The child’s
brain is going through tremendous
development and maturation during
the years prior to age 3. Even up to
age 8 there is significant change.
Damage, either from the tumor itself,
surgery needed to remove the tumor,
radiation therapy, or chemotherapy,
can arrest any further development or
worse yet, cause loss of development
or function. Thus, therapy is
greatly altered in the youngest
ages, moderately so in the middle
childhood ages, and minimally so in
those older than age 8. Due to this,
these patients require a significant
array of services – from diagnosis
through the complex time of therapy,
and throughout the years that
follow – that are pediatric-specific.
Children, based on their tolerance, go
through an intense battery of agespecific tests prior to therapy. These
tests are repeated continuously
throughout and after therapy. For


these to be beneficial, pediatrictrained professionals are critically
important. These professionals
must maintain their expertise, both
through continual education and via
large populations of children with
these disorders. The Neuro-Oncology
team of pediatric professionals at
Children’s Mercy includes oncologists,
neurosurgeons, radiation therapists,
neurologists, rehabilitation medicine,
neuropsychology, endocrinologists,
ophthalmologists, pathologists, and
radiologists. Couple these physicians
with pediatric-specific facilities,
dedicated pediatric oncology units
and clinics and pediatric trained
caregivers including Oncology
dedicated nurses, advanced nurse
specialists, pharmacists, dieticians,
social workers, child life specialists,
and research professionals, and you
get a comprehensive program second
to none in the region.
Children’s Mercy Hospital is one
of the larger Childhood Cancer
Centers, not only in the region, but
also in the country with over 150
children diagnosed annually. Nearly
one fourth of these children are
diagnosed with a brain tumor. The
large volume of children seen with
the tumors leads to an expertise
that is rarely found elsewhere.
With this volume, comes an
efficient organization with excellent
coordination of care under the
auspices of case managers who are
highly trained and specialty specific
advance nurse practitioners. Each
child has their own APN/PA case
manager who works intimately with
their oncologist to oversee and
coordinate all aspects the child’s care
and the family’s support. Be sure to

learn more about us, not only on our
Web site, www.childrensmercy.org,
but also as a featured hospital on the
Children’s Oncology Group’s Web site,
www.curesearch.org .
This year we take great pride in
announcing that Children’s Mercy
is the recipient of this past year’s
American College of Surgeon’s
Commission on Cancer’s Outstanding
Achievement Award, given to the top
six percent of all Cancer Centers in
the country. Our center submits itself
to on-site inspections/surveys every

three years by this commission to
ensure that our continuing goal of
providing the best possible care for
our children is not just words, but
an achieved and measurable reality.
This survey identified that among all
critical areas of care and oversight,
our center achieved outstanding
marks, not just in the year of the
survey, but in all three reviewed years
of activity. This award carries even
more significance as Children’s Mercy
was the only children’s hospital in
the United States to be awarded this
honor. Our belief that we provide

a level of care to our patients that
we would want for our own children,
and that this level of care is among
the best in the country, has been
substantiated by this award. It has
been, and remains our mission to
continue this high level of care for our
current and future patients. I hope
this year’s Annual Report provides
you a glimpse of this as we review our
program for the care of children with
Brain Tumors.

Alan S Gamis, MD, MPH
Chief, Section of Oncology
Division of Hematology/
Oncology & Bone Marrow
Transplantation
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The
Division of
Hematology/
Oncology

Children’s Mercy is the region’s
largest childhood cancer center
averaging nearly 150 new oncology
diagnoses each year. In addition, Children’s
Mercy is the only free-standing hospital made just
for kids from St. Louis to Denver treating children and
adolescents from birth to 21 years of age.
Among the services offered by the Division are:

Case Management - Guided by a nurse case manager, usually
an advanced practice nurse teamed with an oncologist, each
child’s case is overseen from diagnosis through follow-up care. The
Division of Hematology/Oncology recognizes that each child’s and
family’s needs are unique. Consequently, each child’s care is designed
and coordinated specifically for them. The care plan is based on his/
her medical and supportive needs and their developmental level.
Pediatric Hematology/Oncology Fellowship Program – The
Division of Hematology/Oncology at Children’s Mercy Hospital supports
six fellowship positions. Fellows complete a rigorous three year clinical
and research training during their time at Children’s Mercy.
Cancer Care Conferences – Weekly conferences, attended by a
multi-disciplinary team, are held to discuss and deliberate patient
diagnosis and care.
Children’s Mercy Cancer Care Committee (CMCCC) – The CMCCC
provides program oversight to the oncology services. The committee
functions in accordance with the American College of Surgeons’
accreditation standards. Quality improvement in all areas of patient
care is a goal of the committee.

Matthew was diagnosed
with a craniopharyngioma
in 2006. Since then, this 11year-old hasn’t let his brain
tumor slow him down.
He takes his radiation
treatment in stride while
listening to his favorite
artist, Weird Al Yankovic.



The Cancer Registry at Children’s Mercy is a vital
component of the Cancer Program. Under guidance
from federal law, data is collected and maintained on all
patients with malignancies and certain benign tumors.
During 2006, 135 new cases were added to the cancer
registry at Children’s Mercy Hospital. Eligible patients
accessioned in the database now total 1,671. Twentyfour percent of the 2006 cases were diagnoses of the
Central Nervous System, which is the medical focus of
this year’s report

Highlights
The general distribution by diagnostic category is
best shown in the pie chart in Figure 1. The top five
diagnoses continue to include leukemia, brain tumors,
lymphomas, neuroblastoma and osteosarcoma.
Leukemia led the year with 27 percent of the caseload.
(see Table I)

2006 DIAGNOSIS FREQUENCY
Figure 1

CANCER REGISTRY
2006 FREQUENCY OF DIAGNOSIS
TABLE I
Diagnosis
Central Nervous System
Astrocytoma

Percentage

33

24%

12

Glioma

5

Medulloblastoma

3

Ependymoma

1

N.G. Germ Cell

3

Benign/Borderline

9

Leukemia

37

ALL

32

AML

2

Other

3

Lymphoma

14

Non-Hodgkins

6

Hodgkins

8

27%

10%

Neuroblastoma

11

8%

Osteosarcoma

5

4%

Wilms Tumor

5

4%

Rhabdomyosarcoma

4

3%

Ewings Sarcoma (EFT)

2

2%

24

18%

Other
Carcinomas

5

Germ Cell Tumors

2

Malignant Rhabdoid Tumor

1

Melanoma

2

Myelodysplastic Syndrome

1

Retinoblastoma

1

Misc. Reportable Conditions



Totals
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Age and Sex at Diagnosis: The median age of
patients diagnosed during 2006 was 7 years. The age
distribution is shown in Figure 2 with comparison to
past years. The male/female ratio was 73/62 = 1.18
for 2006.
Age range of new diagnoses by year
Figure 2

be collected
because
of local interest.
Please see Table II for
further breakdown of patient
groupings.

2006 Cancer
Registry:
Facts and
Figures

Active follow-up continues on 1,468
patients. The follow-up is maintained on
analytic patients, including benign borderline
CNS cases diagnosed after 1/1/2004. (see Table
II)
By following our patients we contribute to medical
surveillance and make improving patient outcomes
possible.
2006 Survey of Program: The American College of
Surgeons’ Commission on Cancer was initiated in the
1930s. The intent of the program was the establishment
of benchmarks of high standards and systematic program
reviews. Today, these standards continue to promote and

Race and Ethnicity: Race distribution during 2006
included 115 Caucasians, 18 African Americans
and 2 others. Within the 115 Caucasian numbers,
14 patients were designated “Spanish/Hispanic”
ethnicity.
Mortality: There were 24 cancer-related deaths
during 2006. Six of these patients were newly
diagnosed during 2006. Eleven of the patients had a
diagnosis of leukemia and five deaths were related to
brain tumors.
Analytic Patients: During 2006 there were 122
analytic cases. The analytic patient grouping is
included in the statistical analysis of the database and
meet reporting status. Patients diagnosed elsewhere
but treated at Children’s Mercy made up 22 percent
of the cases in 2006. Reportable by agreement cases
are those benign or borderline disease processes
which the Cancer Care Committee has decided should

2006 ACCESSIONED CASES
TABLE II
		
Class of Case
Definition
(Analytic)
0
Diagnosed at CMH /Treated Elsewhere
1
Diagnosed/Treated at CMH
2
Diagnosed Elsewhere/Treated at CMH
(Non-Analytic)
3
Diagnosed/Treated Elsewhere
		
(Treated at CMH for recurrence
		
or disease progression)
Reportable by
Inclusion due to location of tumor or
Agreement
because of propensity to recur.

2006
1
94
27
1
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support multidisciplinary care and improvements to overall
quality. The Children’s Mercy Hospital Cancer Program has
been approved by the Commission on Cancer since 1981.
In August of 2006 the Commission on Cancer
surveyed Children’s Mercy Hospital. Children’s Mercy
Hospital received the Approval Award with a three
year commendation. Our program also achieved the
Outstanding Achievement Award. This honor was awarded
to only seven percent of surveyed programs.


Hannah’s
Heroism

10

On a typical school day, 17-yearold Hannah realized she could
no longer read the projection
screen at the front of the
classroom. For a girl who had
always had perfect vision, this
was troubling. When her vision
was still blurry the next day, her
mother, Tina, brought her to
an eye doctor. After being told
by the eye doctor and a family
care physician that nothing
appeared wrong, Tina and
Hannah were not satisfied.
“I had to cover one of my eyes
so I could see straight,” Hannah
said. “I couldn’t drive or read or
do anything. I was at work with
my hand over one eye!”
Obviously, something was
wrong. Tina brought Hannah to
another doctor, who performed
an MRI. This physician referred
Tina and Hannah
to an oncologist at
Children’s Mercy.
Before the visit,
Hannah’s parents
wanted her to have
a last worry-free
weekend. “They
wouldn’t tell me what
an oncologist was.
They just said brain
doctor.”

On a

tumor. “My parents were
on the floor, crying.”
Hannah recalls. “But
I was kind of relieved
because I knew what
it was now and we just
needed to get rid of it.”
After that, things
happened quickly.
Hannah was in surgery
two days after she was
diagnosed. The inch-anda-half tumor was in the
center of her brain and
could not be surgically
removed. She woke up
to her first 3-day chemo
treatment. The experience was
rather overwhelming for Hannah:
“Two weeks later I just lay in bed. It
was weird. I couldn’t go to school
anymore. I was just lying in my bed
and I had cancer. Who would have
thought that?”

typical school

Dr. Richard Shore takes a look
at Hannah during a recent visit.
Although she had been advised
against it, Hannah decided to shave
it off and wear a wig. After her head
was shaved, “I looked like a boy with
makeup on!” she exclaimed.

day, 17-year-old Hannah
realized she could no
longer read the projection
screen at the front of the
classroom.

That first visit was
difficult. “I had always
thought to myself, ‘I
have three healthy children,’”
Tina said. “That day, I thought,
‘Now I have two. We don’t
belong here.’ I wanted to run.”

Dr. Richard Shore told Hannah
that it was, in fact, a brain

After another two weeks, her long,
brown hair started falling out.
“She couldn’t comb it,” Tina said.
“She kept it pulled up in a pony tail
because it was just falling out left and
right.”

The road to recovery was long
and difficult with 18 weeks of
chemo, 30 days of radiation
and visits to the clinic between.
They lived more than an hour
away and had to come in four
times each week.

Hannah recalled one
particularly rough spot: “I had
to lie on the couch because I
felt like I was going to pass out
if I lifted my head. My dad was
freaking out. He had to carry
me through the hospital’s parking lot.
I was there for three days and then a
week later had to go back for chemo.”
“I knew I was going to be okay from
the beginning. The hardest part was
just knowing everyone thinks you’re
11

going to die and you don’t feel that
way.”
In the midst of these trials were some
bright spots.
Hannah was put on steroids to
decrease the pressure in her brain.
“Within the first week of steroids, my
vision was back. I could see. I was
reading. It was just really good. I knew
if I could see my tumor must have
shrunk,” Hannah said.
Dr. Shore has been Hannah’s
attending physician. “He won’t give
you false hope. He was down to earth.
He wasn’t fake with me,” Hannah
said. “My parents were going crazy.
They took my license, took my car. He
just put me in a room and talked to
me. He told me to milk it at Christmas
because next year I’m not getting
this!”

Hannah lost 30 pounds during
Hannah’s two younger brothers
wanted nothing at Christmas that
her illness. Her parents were so
year but for Hannah to get better.
concerned about how much weight
Their wish came true. The day after
she was losing that they made a
Christmas, the family found
out that Hannah was cancer
free.
Children’s Oncology Group
Tina recalled several
moments that stood out to
her during Hannah’s illness.
“These are the things that
I share with Hannah that
make my heart melt and put
a lump in my throat,” she
said.

Hannah was part of a trial study conducted
by the Children’s Oncology Group. The COG
tries to answer the question: Can there be a
better outcome? Hannah participated in a
study that is looking at how chemotherapy
given before the primary treatment (radiation)
may decrease the time or dose of radiation
needed. This is important because radiation
to the brain can cause loss of memory or
concentration. Hannah will be monitored
periodically by the COG for ten years.

Tina became a little teary
during their first visit back
to the clinic. “I remember
looking around, seeing
parents looking no different
than how I had felt – tired
and emotionally worn out.
I looked at all the beautiful
children playing and getting ready for
chemo. My heart was just breaking
for the children. When I looked at
Hannah I was teary eyed and she
said, ‘Mom, don’t cry. We are all
chosen and blessed.’ My child is
truly amazing.”

During one office visit, Hannah
saw a boy she had seen before
but who was now missing a
leg. A few hours later, the
radiation doctor told her that
it would be longer than she
had expected for her hair to
grow back. Hannah cried
until she remembered the
boy. Then she told Tina, “It’s
okay, Mom. It’s only hair.”
Tina said, “I am a very
lucky mom to have such a
strong and heartwarming
child.”
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bargain with her. If she ate, they
would buy her a brand new car. It
worked.
“I started eating. I wanted a car!”
she said. “May came, school was out
and I went to the dealership with my
parents. We got out and there was my
car. A brand new 2007 Monte Carlo
with balloons all over it and my dad
said ‘get in there.’ I started crying. It
was great.”
Hannah is now a senior in high school
and looking forward to attending
college. She is also enjoying her new
hair. “That hair was dyed. I get new
hair, and it’s really soft.”
Hannah sums up her experience at
Children’s Mercy Hospital: “I don’t
think I could have gotten the same
care anywhere else.”
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Central
Nervous
System
Tumors

Stewart walked on his first birthday. By 15
months, he was saying several words. His
mother also began noticing him holding onto
the wall as he walked. A few weeks later his
walking seemed unsteady and he would keep
heading to the right.
Emily was a good student and loved school. She
especially liked to sit up front near the teacher.
One morning when she woke up to get ready for
school, she had a terrible headache and vomited.
This continued for two weeks.

Roger was a very active young boy.
He loved every sport and he was
good at all of them. Roger was
never sick, but one day on the soccer
field he suddenly began seizing.
13-year-old Lane uses some of
his energy on the playground
in front of Children’s Mercy
and pauses to pose with
his favorite neurosurgeon,
Dr. Clarence Greene, Jr. Dr.
Greene operated on Lane when
he was diagnosed with an
astrocytoma.
Joel was a moody child. His could change from
sweet to angry quite suddenly. When his grades
at school began to decline and he was seeming
more aggressive, his teacher thought that he might
have ADHD. After an evaluation he was started on
medication, but several weeks later his anger seemed
to be more intense and he fought more and more.

The next line in each of these stories is the same: A scan of the head was
done and it showed that the cause of the problem was a brain tumor.
15

Of the many cancers that affect children, almost one third are tumors located in the
central nervous system (CNS). The central nervous system is the part of the nervous
system that includes the brain and the spinal cord. Sadly, in the US approximately
sixteen hundred children are diagnosed each year with a brain tumor. In children,
signs and symptoms of a CNS tumor may vary greatly in both intensity and length.
It is not uncommon for there to be a very prolonged period of time (often months)
between the onset of symptoms and the discovery of a brain tumor. Often the child
has seen one or more health care providers along the way.
At Children’ Mercy, children with CNS tumors are cared for through cooperative
services of specialists from many different areas of the hospital. Included are the
oncologist, but also surgeons, neurosurgeons, radiologists, radiation oncologists,
physical and occupational therapists, nutrionists, pharmacist, psychologists,
researchers, neurologists, nurses, social workers, child life therapists and clergy.
In this report, you will meet some of the real Emilys, Joels, Rogers and Stewarts. You
will also learn about the many specialists here at Children’s Mercy Hospital who are
here to provide all aspects of care needed when the words, “Your child has a brain
tumor” are uttered.

Making the Diagnosis
Radiology

The Department of Radiology is a
vital link in the care of children with
cancer of the central nervous system.
The mission of the members of the
radiology department is to provide
the best possible diagnostic tools
that will enable the Oncology and
Neurosurgical teams to successfully
treat these children. Currently, this is
done by utilizing two state of the art
1.5 Tesla MRI units and 3 multi-slice
CT scanners. These scanners are
integral in brain and spine imaging.
Typically, a child with a tumor of the
brain will be diagnosed after an initial
MRI of the brain and spine. These
pictures localize and characterize
the tumor. They also can show if the
tumor has spread. Once diagnosed
with a tumor, additional advanced
MR imaging may be performed. This
includes diffusion-weighted imaging
16

and MR spectroscopy that allow for
pre-operative characterization of the
tumor, and better surgical planning.
Radiology can also create images
which guide the surgeon in the
operating room.
In 2008 the hospital will open a new,
state of the art MRI center. This center
will house new 3 Tesla and 1.5 Tesla
magnets. These units will include all
available advanced imaging techniques
including white matter tract mapping
and functional localization of eloquent
cortex, to further advance effective
and safe surgical and radiosurgical
planning.
The Department of Radiology commits
itself to obtaining and utilizing the best
technology for the care of children with
central nervous system tumors. Their
work is a vital link in the process of
successful therapy.

Neurosurgical Oncology

Treating a brain tumor often starts
with the neurosurgeon. Many of the
children come to the hospital after
being sick for weeks or months.
Unlike in the adult population, brain
tumors in children grow in the midline
part of the brain. Problems in this
part of the brain produce symptoms
that could have several explanations.
The CMH Neurosurgery team
includes experienced pediatric
nurse practitioners, operating room
nurses, RNFA’s (surgical assistants),
surgical ward RN’s, and a dedicated
outpatient clinic nurse team. All
these individuals work as a unit to
make the
children well
again. They
also strive
to meet the
emotional
and educational needs of the entire
family. They understand that the
course of treatment for a brain tumor
and its associated problems is often
a prolonged and arduous journey.
As tumors grow, more and harsher
symptoms occur. One of these is
hydrocephalus (“water on the brain”).
Hydrocephalus creates increased
pressure within the head (ICP). When
this happens, the neurosurgeon is
frequently called upon to intervene.
The surgeon drains the CSF to relieve
the ICP and stabilize the child. This
important step is done before any
thought can be given to the tumor
mass itself.
The neurosurgical operating suite at
Children’s Mercy Hospital is outfitted
with state-of-the-art equipment that
aids the surgeon in attacking these
problems.

A computer driven NeuroNavigational
disease. The pathologist provides
tool allows the brain imaging
critical information by examining the
(MRI/CT) to be synchronized with
tissue, blood or tumor resections
the child’s
in the
topographic
laboratory.
The
anatomy.
The
The surgeon
pathologist’s
diagnoses are like
can plan an
diagnosis
indicating the way provides
approach that
minimizes
information
to increase the
surgical
necessary to
exposure and
plan optimal
in caring for
risk to the
treatment.
normal brain.
Details
children with cancer...
from the
Advancements
pathologist
in neurosurgery have done
can also estimate the prognosis or
much to decrease the recovery
possible outcome of a particular
time post-surgery. Miniaturized
disease.
neuroendoscopic devises allow the
surgeon to often biopsy tumors
The pathologist has the opportunity
with only nickel-sized openings in
to discuss and present his/her
the head. They can also often treat
findings at clinical multidisciplinary
hydrocephalus without leaving in
conferences
a drainage tube. Direct electric
that involve
recordings (electrocorticagraphy) on
professionals
the surface of the brain can guide
from different
the removal of tumor-effected brain
specialties.
tissue. When this tissue is not
These conferences
removed it can cause epilepsy even
reflect the state of
after the tumor mass is removed.
the art approach
of malignant
neoplasms. At
Pathology
the same time
When a child with a CNS tumor has
they promote
surgery, the pathologist uses the
surgical material to make a diagnosis. collaboration
and team effort in dealing with
Pediatric pathologists have extensive
oncological challenges.
training that includes several years
of specialization after completing
The pathologist’s diagnoses are like
medical school and experience in
road signals indicating the way to
dealing with pediatric conditions that
increase the possibilities of success
are relatively rare in the population.
in caring for children with cancer.
The pathologists are happy to be
Because current medical knowledge
part of a team that makes a positive
and technology offer many choices
contribution to children in need of
of treatment, clinical decisions in
their professional expertise.
oncology are based on accurate
information about a particular

pathologist’s

signals

road

possibilities

of success
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Cytogenetics

While central nervous system (CNS)
tumors are the most common
category of solid tumor in childhood,
there are many different pathologic
types. The cytogenetic laboratory
investigates each child’s tumor for the
presence of genetic anomalies. Fresh
tumor tissue from surgery is grown
by the laboratory in tissue culture.
Chromosomes, the genetic material,
are obtained from the tumor cells and
then analyzed under the microscope
for abnormalities.

A. Karyotype of a choroid plexus papilloma (CPP):
52<2n>,XX,+1,+8,+9,+12,+14,+20
B. Karyotype of a choroid plexus carcinoma (CPC):
32<1n>,XY,+1,+2,-4,+7,+add(12p),add(13p),+add(
14q),-16,+add(18p),add(21q),+4mar
The CP papilloma can be distinguished from
the malignant CP carcinoma by karyotype. The
CP papilloma is commonly hyperdiploid (>46
chromosomes) while the CP carcinoma is often
hyperhaploid (>23 chromosomes

The chromosomes of brain tumors
often show abnormalities. The
abnormalities are often unique to
a particular kind of brain tumor.
By finding the genetic signature
of a tumor cell, determining the
diagnosis may be helped. It may also
provide important information to the
oncologist for therapy selection and
family counseling.
In addition to conventional
chromosome analysis, the cytogenetic
laboratory often uses molecular
cytogenetics or fluorescence in
situ hybridization to detect genetic
aberrations. This method utilizes

additional information with prognostic
significance. New information
regarding the genetics of brain
tumors is always becoming available.
The latest information is used in the
care of the patient with a brain or
CNS tumor.

Neurology

Children with central nervous system
(CNS) tumors present with various
signs and symptoms—ranging from
seizures to motor-skill dysfunction
to sensory losses to behavioral
changes to headache. Many of these
complaints are initially evaluated by
child neurologists. Their workup can
lead to neuroimaging (such as MRI
scans) followed by the subsequent
tests that make the accurate and
specific diagnosis. At Children’s
Mercy Hospital, the Section of
Child Neurology works closely with
the neuro-oncology team to serve
children with a range of tumors within
the CNS.
The mission of the entire Section
of Child Neurology is to improve the
lives of children with all neurological
disorders. This is achieved through
the integration of evidence based

Our cover cutie, 9-year-old
James (JT), looks at a scan of
his brain with Dr. Craig Morriss.
JT’s parents listen as Dr. Morriss
explains more from the scan.
JT was diagnosed with an
astrocytoma in 2000.

DNA probes to search for specific
abnormalities. If present, a specific
anomaly may further define the
disease process and may provide
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clinical care, education and research.
For children diagnosed with tumors
of the central nervous system, we
work closely with other departments
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as multidisciplinary team members
an important part of the eye exam.
dedicated to issues such as disability
In many cases, the first suspicion
management. Individual treatment
of a tumor is the result of a good
plans for each child depend
on the needs of the child
Our family centered
as well as the nature and
extent of the condition.
and
Our family centered and
interdisciplinary approach is approach is designed to

interdisciplinary

encourage parents and
families to make informed
decisions while promoting
health, optimal function,
and
designed to
encourage
parents and
families
to make
informed
decisions
while
promoting health, optimal function,
and quality of life.

dilated exam which allows a thorough
evaluation of the optic nerves. The
initial eye visit provides a baseline
from which to compare any changes
that may occur. This exam includes a
visual acuity assessment of each eye
to detect any loss of vision. Pediatric
ophthalmologists examine children of
all ages and can assess vision even in
the newborn baby.

Ophthalmology

Other important aspects of the eye
exam include assessing the eye
alignment and movement. Children
can have misaligned eyes because of
a tumor. Eye alignment is measured
and followed and treatment is
provided when necessary. Treatment
options can include patching to
relieve double vision or to avoid
developing a “lazy eye.” Eye
movement can also be limited due
to a tumor. Surgical intervention to
realign the eyes is considered only if
the movement deficit is longstanding
and the tumor has been successfully
treated.

Children with CNS tumors may
present to the ophthalmologist in
the eye clinic with symptoms of
headache, blurred or decreased
vision, a “lazy eye,” or double vision.
Results from this exam may lead to
the child being sent for further tumor
workup.

A multidisciplinary team meets
to discuss patients.
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quality of life.

Even when there are no visual
symptoms, all children with CNS
tumors receive an eye exam early
in the course of treatment. These
exams look for problems that may
not even be noticeable to the patient
or parents. Dilation of the eyes is

The Oncology Team

Children receiving oncological care for
their CNS tumor meet their primary
team during the early stages of their
diagnosis. Time is taken to introduce
the members of the team that will
be guiding the care of the child. The
child and family also are told what
needs to happen before treatment
can begin. This is a time to ask
and answer questions. The family
begins the process of understanding
the care that is available for their
child right here at Children’s Mercy
Hospital.

therapist as there may be deficits
related to the tumor and or the
surgical process.

of spreading or recurring. These
types of tumors are often treated with
surgery alone.

The goal of the oncology team
during this time is to help the
patient and family get through the
process of surgery and recovery.
The child’s oncologist follows up
with the pathologists to confirm the
diagnosis and reviews scans with the
radiologist to evaluate objectively the
completeness of surgery.

For the tumors classified as High
Grade or malignant, there is a
higher likelihood of spreading or
recurring. These tumors often require
modalities of treatment (radiation
and/or chemotherapy) along with
surgery. The overall success rate for
these kinds of tumors is closer to 50
percent. Many are significantly poorer
than this. It is for these tumors that
we are continuing to strive to find
better treatments. Many of these

Once the pathology is confirmed and
the tumor location and any spread is

Treatment
The oncologist and neurosurgeon
work closely to coordinate getting
all the testing done as quickly as
possible. While not all brain tumors
are treated the same way, a general
principal is that whatever it is, if the
surgeon can remove the entire tumor
this is always preferable to only a
biopsy. The location of the tumor,
however, can sometimes preclude
anything but a biopsy. Sometimes
even a biopsy is considered too
dangerous to do. Scans can help
determine this, but sometimes what
looks easy to remove on scans is
anything but and what looks like
something that will be very difficult to
remove is not.
Patients usually spend sometime
in the Pediatric Intensive Care Unit
following surgery and once stable
(usually only a couple of days) they
transfer back out to the oncology
inpatient unit. Post surgery, the
patient may have a reason to interact
with our physical and or occupational

identified the oncologist and his/her
team meets again with the family to
review all the information, answer
questions
and discuss
treatment
options.
Oftentimes,
the child
is a part
of this
discussion.
While
overall
success
with treating
brain
tumors is
around 70
percent,
this number
is a somewhat misleading. This
success reflects a large number of
brain tumors that are described as
being low grade or benign. These
tumors do not have a high likelihood

improvements already seen have
come from patients taking part in
clinical trials. Many of these trials are

sponsored by the Children’s Oncology
Group, the leading cooperative group
doing pediatric research studies in
oncology. Locally, all studies are also
reviewed by our Children’s Mercy
21
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Hospital Institutional Review Board.

CNS Research and Clinical
Trials

Research and clinical trials have had
a substantial impact on childhood
cancer for several decades. Through
cooperative research efforts, cure
rates for many childhood cancers
have increased dramatically.
The majority of brain tumor research
at Children’s Mercy is done through a
cooperative effort with the Children’s
Oncology Group (COG). COG is made
up of other children’s hospitals whose
physicians are dedicated to improving
pediatric cancer treatment and
long term outcomes. Clinical trials
approved for enrollment are designed
for specific brain tumor types, such

Among these are the Head Start
protocol which seeks to find less
toxic treatment for younger patients,
and protocols open through the
Pediatric Blood and Marrow
Transplant Consortium. CMH also
enrolls patients on the national
Atypical Teratoid/Rhabdoid tumor
registry. Surgical specimens are
also submitted to research banks for
future research.
In order for patients to participate in
any kind of research, the study must
have IRB approval. The IRB is an
institutional committee that works
together with investigators to make
sure that research is safe for human
subjects. Once there is institutional
approval, the coordinator works with
the treating oncologists to screen

Current and future research will
continue to answer questions and
guide treatment for children with
brain tumors.

Pharmacy

The CMH pharmacy staff is both
knowledgeable about the special
medication needs of pediatric
patients and is ready to provide
services to our oncology patients with
CNS tumors. One of the ways that
the pharmacist helps is by finding the
best way to give children medications.
Because some chemotherapy
medications (e.g. temozolomide,
lomustine & procarbazine) may
only be available for oral use and
in dosage forms not ideal for small
children, special arrangement may
need to be made.

Little 2-year-old Joshua has a
little fun with Dr. Alan Gamis
in the Hematology/Oncology
Clinic. They give each other
a “high-five!” Joshua’s brain
tumor was diagnosed in 2006.

as ependymoma, medulloblastomas,
CNS germ cell tumors, and both low
and high grade gliomas. Once a
patient is enrolled in a research study,
a research coordinator will ensure
that accurate data is submitted to
the research group regarding the
child’s response to the treatment, all
of the side effects encountered and
outcome data during long term follow
up.
Along with COG trials, CMH also
participates in studies in cooperation
with other institutions and groups.

patients who are eligible for each
trial. Many factors play a significant
role to determine whether the child
is able to enroll on the clinical trial.
The research coordinator must
ensure that all pieces of information
from each of the other clinical areas
as well as oncology have met the
requirements laid out in the study
design and implementation. All
patient data submitted must be
accurate, timely and abide by the
federal privacy guidelines.

CNS tumors can also have unique
treatment pathways that involve
the pharmacist. Some brain tumor
patients develop a condition after
surgery or radiation which may
require precise delivery of a hormone
given into the nostrils. In each of
these cases our pharmacists provide
information and education for nurses
and families that allow for safe and
effective use of these drugs - even
in infants! Another chemotherapy
agent, bleomycin, is sometimes
instilled directly onto the surface of a
23

rare tumor occurring in the brain. The
pharmacy staff prepares a special
mixture of this drug when needed for
this purpose.

Pharmacists dedicated to the
oncology service are always available
to provide advice on the use and side
effects of any drugs.

Radiation Oncology

Radiation therapy has long been a
standard treatment modality for brain
tumors. The techniques, delivery
precision, and doses have evolved
over the years to tailor therapy to
best suit the tumor histology, location
of the tumor, and even the child’s
age. Indications for radiation first
are determined by the cell type and
extent of involvement. Combined
modality treatments have altered
the timing, and in some cases
the doses of radiation used. The
volumes treated by radiation therapy
are determined by the location at
diagnosis and histology, because
the patterns of failure and spread
are related to these directly. One of
the most important improvements
to occur has been the precision of
24

delivery, with our ability to better
target the region of interest. In spite
of improvements in radiation, we
recognize that young patients often
suffer devastating consequences
related to therapy.
IMRT, an advanced
method to focus
radiation, is
employed whenever
indicated for the
child. By working as
a team, we can offer
the best therapy for
each patient, offering
improved cures and
optimal quality of life,
as well. Children’s
Mercy has partnered
with Kansas City
Cancer Centers and
The Gamma Knife
to offer the most effective treatment
options to patients.

Transplant

cases, radiation is added to kill even
more cancer cells.
This kind of therapy also damages
normal tissues. Bone marrow is
affected the most. After this high
dose therapy, the bone marrow may
take a very long time to recover or it
may never recover. A person cannot
live without a working bone marrow.
A stem cell rescue or autologous
transplant gives back saved healthy
stem cells that can make the bone
marrow work again. Stem cells are
collected when the bone marrow is
still healthy. These stem cells are
frozen in the laboratory and saved
until needed. Some children with CNS
tumors have stem cells collected, but
never have to use them.
When cells are needed, they are
thawed and returned into a vein of
the patient. The healthy stem cells
then grow and the blood counts and
immune system gradually return to
normal.

Chemotherapy and radiation therapy
have been used for many years to
treat CNS tumors. For more than
a decade, autologous
5 YEAR RELATIVE SURVIVAL RATES FOR CNS TUMORS
stem cell rescue has also
NATIONAL / CMH COMPARISONS
been used in treatment.
HISTOLOGY 	ICDO Code
SEER 1973- CMH 1990(s)
2002
2004
Chemotherapy and
Astrocytoma, NOS
9400
76.6%
86.5%
radiation work by killing
			
(n=30)
cancer cells. Higher
Pilocytic
9421
94.2%
97.3%
Astrocytoma			
(n=77)
doses of treatment are
Anaplastic
9401, 9411
50.7%
33.3%
sometimes used so more
Astrocytoma			
(n=3)
cancer cells can be killed
Ependymoma/
9391, 9393
54.7%
57.1%
anaplastic			
(n=23)
at once. One reason
ependymoma
to do this is because
Embryonal /PNET/
8963, 947055.7%
52.4%
cancer cells can become
Medulloblastoma
9473		
(n=59)
9502-9503
resistant to chemotherapy
Glioma,
malignant,
9380
47.3%
61.3%
(chemotherapy drugs no
NOS			
(n=34)
longer kill the cells). The
Glioblastoma
9440-9441
19%
14.3%
			
(n=7)
higher doses of the same
Germ Cell, CNS
9064,
85.6%
90.9%
chemotherapy drugs
SEER 1996-2003
9080-9085,		
(n=11)
may be able to kill these
9070-9071,
9100-9101
resistant cells. In some

Social Work

A variety of services are provided
through our psychosocial team.
Social workers are an integral part
of the team as they demonstrate
the importance we place on
comprehensive, family centered
care. Our social workers are Master’s
-prepared and each has expertise
serving the needs of our children
and their families. Each social
worker works closely with a primary
oncologist and advanced practice
nurse to become the patient and
family’s ‘primary team’.
This team approach is especially
important for the child or adolescent
with a CNS tumor. At diagnosis, the
primary team sits down with the
patient’s family and patient (when

and emotionally from the diagnosis.
In addition, when appropriate, they
refer patients and families to other
psychosocial team members such
as child life, chaplaincy, and child
psychology.
For school-age children, social
workers meet with the parents and
the school to ensure that the child’s
educational needs are being met.
Social workers attend IEP (individual
educational plan) meetings with
parents to assist with developing a
plan that the patient can accomplish
both during and after treatment.
Social workers also provide
supportive counseling to the patient
and fellow students as the patient
returns to school following diagnosis
and treatment.

support group setting. The program
also offers bereavement services
to families. A network of parent
volunteers who have lost children
supports this service.
Referrals are also made to vocational
and rehabilitation services as
needed. These programs can help
children keep up with daily tasks, as
well as learn future skills. Necessary
and accessible medical equipment
is also obtained. At parents’
request, social workers assist with
the application for Social Security
Disability benefits.
In addition to the Parent to Parent
support, social workers also offer
counseling and support to families
who are grieving the loss of a child.

Support
age appropriate). As a group, they
discuss the diagnosis, treatment plan
and begin to answer questions. The
social worker provides supportive
counseling and assists the family
in organizing their own resources.
They also begin identifying additional
resources that could aid the family in
the journey ahead.
The social worker completes a
psychosocial assessment on each
patient. This forms the basis for the
subsequent relationship with the
child and family. The assessment
aids the family and social worker
in determining the resources and
assistance needed as well as making
preparations to begin treatment.
Social workers provide counseling
and active listening as patients and
families begin to heal both physically

Social workers refer patients and
their families to outside agencies for
support and financial assistance.
Families get assistance from such
groups as the Pediatric Brain Tumor
organization, American Cancer
Society, Turning Point and Solace
House. Referrals for lodging and
transportation assistance, are also
given when appropriate.
CMH offers an exciting Parent to
Parent program, coordinated by
one of our social workers. In this
program, experienced parents of
children with cancer volunteer their
time and are paired with a family
with newly diagnosed children. The
volunteer shares their expertise and
offers support. This unique team has
been much more successful than the

Families are guided through the
funeral process and continue to
receive support once outside the
hospital. Both internal bereavement
groups and outside resources are
offered in order to best meet the
needs of each individual family.
Social workers realize that
treatment is not merely a series of
chemotherapy, clinic appointments,
radiation therapy and inpatient
hospitalizations. It is a process
where the most important outcome
is that the patient and family are
able to define their ‘new normal’
after treatment ends. For many of
our patients with CNS tumors, their
lives will never be the same. They
will require adjustment, assistance,
equipment and opportunities to
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compensate for lost functions. As
part of an ongoing partnership
with each patient and family, social
workers consider it their privilege
to accompany patients and families
on their journey and bear witness
to their determination, courage and
resilience.

Developmental Medicine

No parent ever anticipates that
they will ever hear the words “Your
child has a brain tumor.” Families
frequently experience fear, anger,
anxiety, sadness and depression.
At the same time they feel hope,
determination and optimism.
While there are few things more

unit services can be offered to the
patient, siblings and parents. In
addition to a designated psychologist
who works closely with the Division of
Hematology/Oncology, consultative
services with a psychiatrist and family
therapist are also available.
Along with the emotional impact
on a child, brain tumors and their
treatment can lead to changes in
cognitive functioning. Children
can have changes in how they
problem solve, memory, attention,
and processing speed. These
changes can lead to problems
in school. We routinely provide
evaluations to children diagnosed

Child Life Specialists

Child Life specialists dedicated to the
Hematology/Oncology Division are
available in the outpatient clinic, on
4 Henson the inpatient floor and in
the Bone Marrow Transplant unit. A
Child Life specialist is trained to meet
the developmental, emotional and
psycho-social needs of children and
their families. They accomplish this
by advocating for children in all areas
of the hospital.
Child Life specialists can be seen
playing with children or “hanging
out” with teens. They recognize
“play” as a child’s “work” – allowing
the building of rapport with children

Little 2-year-old Joseph is
ready to play with Child Life
Specialist Amanda Woelk in
the Hematology/Oncology
playroom. Joseph had surgery
for an ependymoma in 2007.

stressful in life than having to deal
with cancer in a child, a cancer
discovered in the brain adds ever
more challenges.
The Section of Developmental
and Behavioral Sciences offers
comprehensive psychological services
to children and families affected by
these tumors. Services are tailored
to the needs of each child and family.
Staff members counsel as well as
facilitate coping with the stressors
that accompany the diagnosis and
treatment. Counseling can be done
both on the inpatient unit, and in
the Developmental and Behavioral
Sciences Clinic. Individual or family
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with brain tumors, and other CNS
cancers. These evaluations help
to identify any cognitive/learning
areas that treatment might
impact. This information is used
to monitor progress over the years
and to assist the child, parent and
school in developing individualized
educational plans that maximize
the child’s learning potential and
ease frustration. Staff can assist
the family in communicating with
the child’s school. They can relay
information regarding the unique
strengths and challenges of each
child, as well as what the school,
family and medical team can do to
support that child.

and helping them to adjust to
hospitalization, diagnosis, and
understanding.
Child Life specialists aid in pain
management and facilitate positive
coping skills. They also are there
to help the child adjust to their
new diagnosis and the life changes
that come with it. The Child Life
specialist works to provide multiple
opportunities for socialization and
peer interaction. They also provide
sibling support in their role.
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2401 Gillham Road
Kansas City, MO 64108
(816) 234-3000
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